I think the otc excuse though is only half the problem. Generex was at 3.29 last July on the OTC, so it can be well above what it is now without anything concerning the virus issue.
That’s why it’s so important that Generex comes out with information on the Generex S-1, funding and all of their other products.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links